Artículos de revistas
Modulation of doxorubicin-induced clastogenesis in Wistar rat bone marrow cells by vitamin B(6)
Fecha
2008Registro en:
ARCHIVES OF TOXICOLOGY, v.82, n.11, p.869-873, 2008
0340-5761
10.1007/s00204-008-0308-8
Autor
TAKEUCHI, Paula Lumy
ANTUNES, Lusania Maria Greggi
TAKAHASHI, Catarina Satie
Institución
Resumen
Vitamin B(6) has shown to be a potentially effective antioxidant agent, and dietary antioxidants are also frequently valuable inhibitors of clastogenesis and carcinogenesis. The purpose of the present work was to study the clastogenicity of different doses of vitamin B6 and to examine the possible modulating effect of this vitamin on chromosomal damage induced by the antitumor agent doxorubicin in Wistar rats. Experimental groups were set up for pre-and simultaneous treatment with vitamin B6 alone or in combination with DXR. The data obtained from administering diVerent doses of vitamin B(6) (12.5-100 mg/kg b. w.) showed no signigicant increase in total chromosomal aberrations when compared with the negative control. The administration of two doses of 25 mg/kg b. w. or one dose of 50 mg/kg b. w. of vitamin B6 before doxorubicin injection seemed equally effective in protecting cells against doxorubicin clastogenicity. The anticlastogenic effect of vitamin B(6) on DXR-induced chromosomal damage could be ascribed to its antioxidant properties. Vitamin B6 was not clastogenic or cytotoxic in rat bone marrow cells and it plays a role in inhibiting the clastogenicity induced by DXR.